In addition, chemotherapy reduces inhibitory checkpoint molecules in pancreatic cancer including CD80/CD86-CTLA4, LGALS9-HAVCR2, DPCD1LG2-PDCD1, and TIGIT-PVR [33,121]. This evidence concerns the gene CTLA4 and pancreatic neoplasm.